# Anterion Therapeutics, Inc. — Form D

Anterion Therapeutics, Inc. of SALEM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-02. $900K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-03-02
- Form: D
- Accession: 0001485558-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Amount sold: $900K
- Minimum investment: $10K
- Investors: 9
- Date of first sale: 2007-06-22
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-139183

## Issuer

- Name: Anterion Therapeutics, Inc.
- CIK: 0001485558
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 35 CONGRESS STREET, SALEM, MA, 01970
- Phone: 9786664406

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Kim John Emerling | Director | Salem, MA |
| Robert J Leonard | Director | Swampscott, MA |
| Richard John Millian | Director | Boston, MA |
| Barry John Unger | Director | Cambridge, MA |
| Jean-Marie John Vallet | Director | Brookline, MA |
| Charles P Wilkinson | Director | Swampscott, MA |
| Robert J Leonard | Executive Officer | Swampscott, MA |
| Richard John Millian | Executive Officer | Boston, MA |

## More

- [CIK 1485558 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1485558&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001485558-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.